Smithfield Trust CO Astrazeneca PLC Transaction History
Smithfield Trust CO
- $2.24 Billion
- Q3 2025
A detailed history of Smithfield Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Smithfield Trust CO holds 3,978 shares of AZN stock, worth $355,633. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,978
Previous 3,978
-0.0%
Holding current value
$355,633
Previous $279,000
8.96%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding AZN
# of Institutions
1,507Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...